PYXS
Pyxis Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.89
+9.12%Margins
Gross margin
99.8%
EBITDA margin
-755.9%
EBIT margin
-834.4%
Net margin
-803.8%
FCF margin
-615.3%
-775.6%
Return on equity
-161.6%
Return on assets
-314.7%
Return on invested capital
0.19x
Asset turnover
-$67.9M
Cash from operations
$0.40
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026